Research Article
BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death
Table 1
Characteristics of primary AML samples.
| BSMS number | Sex | Age | Diagnosis | Cytogenetics | Gene Mutations |
| 0131 | F | 75 | AML | Normal | None detected | 1007 | M | 58 | AML | Normal | NPM1 mutated | 1010 | M | 76 | AML | Normal | None detected | 1013 | M | 76 | AML | Normal | None detected | 1015 | M | 85 | AML | Normal | None detected | 1019 | M | 33 | AML | Inv16 | None detected | 1022 | M | 76 | AML | Normal | None detected | 1024 | M | 68 | AML | Normal | None detected | 1026 | M | 75 | AML | Normal | None detected | 1030 | M | 70 | AML | Normal | DNMT3A, FLT3, TET, SRSF2 mutations | 1031 | M | 60 | AML | Normal | None detected | 1032 | M | 52 | AML | Normal | None detected | 1033 | M | 72 | AML | Normal | TET2, SRSF2, ASXL1, RUNX1 mutations | 1036 | M | 74 | AML | Normal | None detected | 1037 | M | 48 | AML | Normal | NPM1, FLT3 mutated | 1038 | M | 74 | AML | Monosomy 7 | None detected | 1041 | F | 81 | AML | Normal | None detected | 1045 | M | 57 | AML | Normal | FLT3 mutated |
|
|